These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 18095109
1. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion. Tsunoda K, Kitange G, Anda T, Shabani HK, Kaminogo M, Shibata S, Nagata I. Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109 [Abstract] [Full Text] [Related]
3. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M. Clin Cancer Res; 2001 Dec; 7(12):4136-42. PubMed ID: 11751513 [Abstract] [Full Text] [Related]
4. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F. Cancer; 2008 May 15; 112(10):2258-66. PubMed ID: 18327814 [Abstract] [Full Text] [Related]
5. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO. Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951 [Abstract] [Full Text] [Related]
6. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M, Naito S. Lab Invest; 1999 Apr 15; 79(4):407-16. PubMed ID: 10211993 [Abstract] [Full Text] [Related]
7. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Chang HJ, Kim MH, Baek MK, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD. Anticancer Res; 2007 Apr 15; 27(5A):3411-7. PubMed ID: 17970088 [Abstract] [Full Text] [Related]
8. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y, Kazimirsky G, Sarid R, Brodie C. Cancer Res; 2006 Apr 15; 66(8):4139-48. PubMed ID: 16618735 [Abstract] [Full Text] [Related]
13. [Epidermal growth factor-mediated NF-kappaB activation promotes uPA expression and invasiveness in pancreatic cancer cells]. Zhang H, Liu XF, Li YJ, Zhou JP, Kong FM, Dong M. Zhonghua Zhong Liu Za Zhi; 2007 Dec 01; 29(12):909-12. PubMed ID: 18478929 [Abstract] [Full Text] [Related]
14. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, Rao JS. Cancer Res; 1994 Sep 15; 54(18):5016-20. PubMed ID: 8069869 [Abstract] [Full Text] [Related]
15. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Mishima K, Kato Y, Kaneko MK, Nishikawa R, Hirose T, Matsutani M. Acta Neuropathol; 2006 May 15; 111(5):483-8. PubMed ID: 16596424 [Abstract] [Full Text] [Related]
16. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Kim SY, Kim DH, Han SJ, Hyun JW, Kim HS. Biochem Pharmacol; 2007 Dec 03; 74(11):1642-51. PubMed ID: 17880928 [Abstract] [Full Text] [Related]
17. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression. Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH, Kim HS. Chem Biol Interact; 2010 Apr 15; 185(1):18-24. PubMed ID: 20188714 [Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. Seo SI, Song SY, Kang MR, Kim MS, Oh JE, Kim YR, Lee JY, Yoo NJ, Lee SH. APMIS; 2009 Aug 15; 117(8):623-8. PubMed ID: 19664134 [Abstract] [Full Text] [Related]